**The primary driver of trader sentiment is the record-shattering 2026 cyclosporiasis season, with CDC data showing 17,180 laboratory-confirmed domestically acquired cases from May 1 through August 24—more than 14 times the 1,180 cases recorded over the same period in 2025.** A major multistate outbreak tied to processed iceberg lettuce from central Mexico accounts for a substantial share of illnesses, alongside at least six other clusters under investigation by CDC and FDA. Cases span 48 states plus D.C., with 922 hospitalizations and two deaths reported; median symptom onset was July 7. Cyclosporiasis, caused by the Cyclospora cayetanensis parasite and typically transmitted via contaminated fresh produce, follows a pronounced seasonal pattern peaking in summer. Because confirmation involves lab testing, patient interviews, and reporting lags, final August 31 totals may rise further even after the official season closes, directly shaping market resolution.
Resumo experimental gerado por IA com dados do Polymarket. Isto não é aconselhamento de trading e não tem qualquer papel na resolução deste mercado. · AtualizadoCasos de ciclosporíase nos EUA até 31 de agosto?
Casos de ciclosporíase nos EUA até 31 de agosto?
$13,103 Vol.
31 ago 2026
10.000+
Sim
15.000+
Sim
20.000+
Não
$13,103 Vol.
10.000+
$2,454 Vol.
Sim
15.000+
$4,592 Vol.
Sim
20.000+
$6,057 Vol.
Não
This market will resolve to "Yes" if there have been the specified amount or more confirmed domestically acquired cases of cyclosporiasis in humans in the territory of the United States of America since May 1, 2026, according to the CDC surveillance count by August 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Surveillance of Cyclosporiasis page’s “U.S. cases reported to CDC” count (see: https://www.cdc.gov/cyclosporiasis/php/surveillance/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC as confirmed domestically acquired cases of cyclosporiasis will qualify, regardless of reports from U.S. State agencies or other sources. Travel-associated cases acquired outside the United States will not qualify.**The primary driver of trader sentiment is the record-shattering 2026 cyclosporiasis season, with CDC data showing 17,180 laboratory-confirmed domestically acquired cases from May 1 through August 24—more than 14 times the 1,180 cases recorded over the same period in 2025.** A major multistate outbreak tied to processed iceberg lettuce from central Mexico accounts for a substantial share of illnesses, alongside at least six other clusters under investigation by CDC and FDA. Cases span 48 states plus D.C., with 922 hospitalizations and two deaths reported; median symptom onset was July 7. Cyclosporiasis, caused by the Cyclospora cayetanensis parasite and typically transmitted via contaminated fresh produce, follows a pronounced seasonal pattern peaking in summer. Because confirmation involves lab testing, patient interviews, and reporting lags, final August 31 totals may rise further even after the official season closes, directly shaping market resolution.
This market will resolve to "Yes" if there have been the specified amount or more confirmed domestically acquired cases of cyclosporiasis in humans in the territory of the United States of America since May 1, 2026, according to the CDC surveillance count by August 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Surveillance of Cyclosporiasis page’s “U.S. cases reported to CDC” count (see: https://www.cdc.gov/cyclosporiasis/php/surveillance/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC as confirmed domestically acquired cases of cyclosporiasis will qualify, regardless of reports from U.S. State agencies or other sources. Travel-associated cases acquired outside the United States will not qualify.
The resolution source for this market will be the CDC Surveillance of Cyclosporiasis page’s “U.S. cases reported to CDC” count (see: https://www.cdc.gov/cyclosporiasis/php/surveillance/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC as confirmed domestically acquired cases of cyclosporiasis will qualify, regardless of reports from U.S. State agencies or other sources. Travel-associated cases acquired outside the United States will not qualify.
Mercado Aberto: Jul 27, 2026, 11:16 PM ET
Volume
$13,103Data de Término
1 set 2026Mercado Aberto
Jul 27, 2026, 11:16 PM ETResolver
0x65070BE91...Resultado proposto: Sim
Sem contestação
Resultado final: Sim
This market will resolve to "Yes" if there have been the specified amount or more confirmed domestically acquired cases of cyclosporiasis in humans in the territory of the United States of America since May 1, 2026, according to the CDC surveillance count by August 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Surveillance of Cyclosporiasis page’s “U.S. cases reported to CDC” count (see: https://www.cdc.gov/cyclosporiasis/php/surveillance/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC as confirmed domestically acquired cases of cyclosporiasis will qualify, regardless of reports from U.S. State agencies or other sources. Travel-associated cases acquired outside the United States will not qualify.**The primary driver of trader sentiment is the record-shattering 2026 cyclosporiasis season, with CDC data showing 17,180 laboratory-confirmed domestically acquired cases from May 1 through August 24—more than 14 times the 1,180 cases recorded over the same period in 2025.** A major multistate outbreak tied to processed iceberg lettuce from central Mexico accounts for a substantial share of illnesses, alongside at least six other clusters under investigation by CDC and FDA. Cases span 48 states plus D.C., with 922 hospitalizations and two deaths reported; median symptom onset was July 7. Cyclosporiasis, caused by the Cyclospora cayetanensis parasite and typically transmitted via contaminated fresh produce, follows a pronounced seasonal pattern peaking in summer. Because confirmation involves lab testing, patient interviews, and reporting lags, final August 31 totals may rise further even after the official season closes, directly shaping market resolution.
This market will resolve to "Yes" if there have been the specified amount or more confirmed domestically acquired cases of cyclosporiasis in humans in the territory of the United States of America since May 1, 2026, according to the CDC surveillance count by August 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Surveillance of Cyclosporiasis page’s “U.S. cases reported to CDC” count (see: https://www.cdc.gov/cyclosporiasis/php/surveillance/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC as confirmed domestically acquired cases of cyclosporiasis will qualify, regardless of reports from U.S. State agencies or other sources. Travel-associated cases acquired outside the United States will not qualify.
The resolution source for this market will be the CDC Surveillance of Cyclosporiasis page’s “U.S. cases reported to CDC” count (see: https://www.cdc.gov/cyclosporiasis/php/surveillance/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC as confirmed domestically acquired cases of cyclosporiasis will qualify, regardless of reports from U.S. State agencies or other sources. Travel-associated cases acquired outside the United States will not qualify.
Volume
$13,103Data de Término
1 set 2026Mercado Aberto
Jul 27, 2026, 11:16 PM ETResolver
0x65070BE91...Resultado proposto: Sim
Sem contestação
Resultado final: Sim
**The primary driver of trader sentiment is the record-shattering 2026 cyclosporiasis season, with CDC data showing 17,180 laboratory-confirmed domestically acquired cases from May 1 through August 24—more than 14 times the 1,180 cases recorded over the same period in 2025.** A major multistate outbreak tied to processed iceberg lettuce from central Mexico accounts for a substantial share of illnesses, alongside at least six other clusters under investigation by CDC and FDA. Cases span 48 states plus D.C., with 922 hospitalizations and two deaths reported; median symptom onset was July 7. Cyclosporiasis, caused by the Cyclospora cayetanensis parasite and typically transmitted via contaminated fresh produce, follows a pronounced seasonal pattern peaking in summer. Because confirmation involves lab testing, patient interviews, and reporting lags, final August 31 totals may rise further even after the official season closes, directly shaping market resolution.
Resumo experimental gerado por IA com dados do Polymarket. Isto não é aconselhamento de trading e não tem qualquer papel na resolução deste mercado. · Atualizado
Cuidado com os links externos.
Cuidado com os links externos.
Frequently Asked Questions